Pitfalls in the sample preparation and analysis of N-acylethanolamines.
N-acylethanolamines (NAEs) are a group of lipid mediators synthesized in response to a number of physiological and pathological stimuli. Because of the low tissue concentrations of NAEs, analyses often include liquid extraction followed by solid-phase extraction and subsequent quantitation by LC/MS or GC/MS. Reported levels of NAEs vary considerably, however, and often no explanation is given for these discrepancies. Brought on by difficulties encountered during method development, the effects of using four different brands of silica-containing solid phase extraction (SPE) columns and five different brands of chloroform for sample preparation were investigated. Considerable variation in the retention and recoveries of seven NAEs and 2-arachidonoylglycerol existed between the SPE columns. Furthermore, it was found that some chloroforms contained quantifiable amounts of N-palmitoylethanolamine and N-stearoylethanolamine. Finally, it was found that use of one of the chloroforms resulted in a loss of N-oleoylethanolamine from solution due to addition of chlorine to the ω-9 bond. The identity of this reaction product was confirmed by LC-MS/MS and NMR. It is recommended that these aspects of sample preparation and analysis should be thoroughly validated during method development and the relevant information on specific brands used be reported in future communications in order to better estimate the validity of reported quantitative data.
Skonberg
Christian
C
Department of Pharmaceutics and Analytical Chemistry, Faculty of Pharmaceutical Sciences, University of Copenhagen, Copenhagen, Denmark. cs@farma.ku.dk
Artmann
Andreas
A
Cornett
Claus
C
Hansen
Steen Honoré
SH
Hansen
Harald S
HS
D001095:Arachidonic Acids; D002853:Chromatography, Liquid / Q000379:methods; D063388:Endocannabinoids; D004983:Ethanolamines / Q000032:analysis*; D008401:Gas Chromatography-Mass Spectrometry; D005989:Glycerides; D013058:Mass Spectrometry; D052616:Solid Phase Extraction / Q000379:methods*
D001095:Arachidonic Acids; D063388:Endocannabinoids; D004983:Ethanolamines; D005989:Glycerides; C022203:N-acylethanolamines; C094503:glyceryl 2-arachidonate
Vet Immunol Immunopathol. 2010 Jan 15;133(1):9-15
19625089
Chem Phys Lipids. 2000 Nov;108(1-2):135-50
11106787
J Pharmacol Exp Ther. 2006 Dec;319(3):1051-61
16997973
Biochem Pharmacol. 2009 Sep 15;78(6):553-60
19413995
Synapse. 1999 Sep 1;33(3):181-91
10420166
Biochem Biophys Res Commun. 1999 Mar 16;256(2):377-80
10079192
Science. 1992 Dec 18;258(5090):1946-9
1470919
J Chromatogr B Biomed Sci Appl. 1997 Mar 7;690(1-2):7-13
9106024
Anal Biochem. 2003 Mar 1;314(1):8-15
12633597
J Neuroendocrinol. 2008 May;20 Suppl 1:94-9
18426507
Anal Biochem. 2000 Apr 10;280(1):87-93
10805525
J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Sep 15;877(26):2909-23
19414283
Anal Sci. 2003 Dec;19(12):1593-8
14696920
J Neurosci. 2000 May 1;20(9):3401-7
10777802
J Biol Chem. 1957 May;226(1):497-509
13428781
Anal Biochem. 2008 Feb 15;373(2):220-8
17981259
Chem Phys Lipids. 2000 Feb;104(2):185-91
10669310
J Neuroendocrinol. 2008 May;20 Suppl 1:39-46
18426498
J Neurochem. 2007 Dec;103(5):1907-16
17868306
Curr Opin Chem Biol. 2009 Jun;13(3):321-31
19497779
J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Jul 15;877(22):2052-60
19535304
Biochem J. 2002 Aug 15;366(Pt 1):137-44
12010121
Prostaglandins Leukot Essent Fatty Acids. 1995 Oct;53(4):301-8
8577784
Am J Physiol Regul Integr Comp Physiol. 2008 Jul;295(1):R45-50
18434444
Mass Spectrom Rev. 2003 Mar-Apr;22(2):81-152
12820273
Chem Phys Lipids. 2002 Dec 31;121(1-2):111-34
12505695
J Neurochem. 2000 Dec;75(6):2434-44
11080195
Anal Biochem. 2007 Jan 15;360(2):216-26
17141174
Biochim Biophys Acta. 2008 Apr;1781(4):200-12
18316044
Prostaglandins Other Lipid Mediat. 2006 Dec;81(3-4):106-12
17085319
Neurochem Int. 2009 Mar-Apr;54(3-4):199-204
19100800
Anal Biochem. 2009 Dec 1;395(1):68-76
19665986